Why Is There No Food and Drug Administration–Approved Medication for Major Depression With Psychotic Features? episode artwork

EPISODE · Jun 23, 2021 · 12 MIN

Why Is There No Food and Drug Administration–Approved Medication for Major Depression With Psychotic Features?

from The Journal of Clinical Psychopharmacology Podcast

Psychotic depression is a severely disabling illness and is more common than is generally realized. Unfortunately, there is no FDA-approved medication for its treatment. In this podcast, the Editor-in-Chief of the Journal of Clinical Psychopharmacology, Anthony J. Rothschild, discusses his opinions as to how this came about and encourages further research and development of a suitable medication with an eye toward FDA approval.

NOW PLAYING

Why Is There No Food and Drug Administration–Approved Medication for Major Depression With Psychotic Features?

0:00 12:07

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Journal of Clinical Psychopharmacology Podcast?

This episode is 12 minutes long.

When was this The Journal of Clinical Psychopharmacology Podcast episode published?

This episode was published on June 23, 2021.

What is this episode about?

Psychotic depression is a severely disabling illness and is more common than is generally realized. Unfortunately, there is no FDA-approved medication for its treatment. In this podcast, the Editor-in-Chief of the Journal of Clinical...

Can I download this The Journal of Clinical Psychopharmacology Podcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!